This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Cat Vaccine industry.
What is the projected value of the cat vaccine market by 2029?
The cat vaccine market size has grown strongly in recent years. It will grow from $1.15 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising emergence of new diseases in cats, increasing prevalence of animal diseases, increasing livestock population of animals, increasing population of companion animals, and increasing zoonotic diseases.
The cat vaccine market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the rising trend of pet ownership, increasing disposable income, increasing demand for veterinary services, government and veterinary organization initiatives, and growing awareness of animal health among people. Major trends in the forecast period include development of advanced cat vaccines, innovative and more effective products, novel vaccine technologies, innovations in combination vaccines, and the development of personalized vaccinations.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp
How are technological advancements fueling growth in the cat vaccine market?
The increasing prevalence of zoonotic diseases is expected to propel the growth of the cat vaccine market going forward. Zoonotic diseases are infections that can pass from animals to humans, caused by pathogens such as bacteria, viruses, fungi, or parasites. These diseases can spread through direct contact, vectors, or contaminated environments. The common zoonotic diseases are lyme disease, rabies, toxoplasmosis, salmonellosis, brucellosis, and more. The increasing prevalence of zoonotic diseases is due to climate change, antibiotic resistance, and illegal and legal wildlife trade. Cat vaccines control zoonotic diseases by reducing the risk of transmission from cats to humans by vaccinating cats against diseases such as toxoplasmosis and cat scratch fever. This proactive approach helps mitigate zoonotic diseases’ impact on human health, supports public health efforts, and ensures a healthier environment for pets and their owners. For instance, in February 2024, according to a report published by the Government of the United Kingdom, in the fourth quarter of 2023, England reported 335 confirmed cases of Lyme disease, an increase from the 273 cases recorded during the same period in 2022. Therefore, the increasing zoonotic diseases drive the cat vaccine market.
Which segment currently leads the cat vaccine market in terms of revenue share?
The cat vaccine market covered in this report is segmented –
1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types
2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Diseases
3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
4) By Route Of Administration: Injectables, Intranasal, Oral
5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers
Subsegments:
1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine
2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine
3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report
What technological trends are expected to redefine the cat vaccine market?
Major companies operating in the cat vaccine market are focused on developing innovative products such as NOBIVAC NXT vaccines that utilize state-of-the-art Ribonucleic acid (RNA)-particle technology to enhance immune responses, improve vaccine efficacy, and provide targeted protection against feline diseases. State-of-the-art Ribonucleic acid (RNA)-particle technology is an innovative approach that uses RNA molecules encapsulated in nanoparticles to deliver genetic instructions to cells, prompting them to produce specific proteins that stimulate a targeted immune response. For instance, in June 2024, MSD Animal Health Inc., a US-based pharmaceutical company, launched The NOBIVAC NXT Rabies portfolio consists of NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies, a comprehensive vaccination solution designed to provide effective protection against rabies in cats and dogs. The NOBIVAC NXT vaccines are formulated without adjuvants and preservatives, enhancing their safety profile while maintaining efficacy. The vaccines stimulate both humoral (antibody-mediated) and cell-mediated immune responses, providing comprehensive protection against the rabies virus.
Who are the top competitors in the global cat vaccine market?
Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale, Virbac, Neogen Corporation, Indian Immunologicals Ltd., Jinyu Bio-technology Co. Ltd., Ourofino Animal Health SA, Biogénesis Bagó SA, Valley Vet Supply, HIPRA Corporation, Bioveta AS, China Animal Husbandry Group, Veterinary Pharmaceutical Solutions, Torigen Pharmaceuticals Inc., KM Vet Pharm Sdn Bhd.
What regional dynamics are shaping the future of the global cat vaccine market?
North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Cat Vaccine Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20526
Need Customized Data On Cat Vaccine Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20526&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
